New names for old disciplines

Journal of Inherited Metabolic Disease

Volumn 25, Issue 3, 2002, Pages 139-156

  Galjaard, H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CONGENITAL DISORDER; CONTROLLED STUDY; FEMALE; GENE MAPPING; GENETIC COUNSELING; GENETIC DISORDER; GENOMICS; HEALTH CARE ACCESS; HUMAN; HUMAN GENOME; INBORN ERROR OF METABOLISM; LABORATORY DIAGNOSIS; MALE; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PHARMACOGENOMICS; PREDICTION; PRENATAL DIAGNOSIS; PROTEOMICS; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; CHEMISTRY; GENETIC LINKAGE; GENETICS; RISK REDUCTION;

DNA; HUMAN; LINKAGE (GENETICS); METABOLISM, INBORN ERRORS; RISK REDUCTION BEHAVIOR; HUMANS;

EID: 0035990289     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015669626590     Document Type: Article

References (63)

1. BRCA1 and BRCA2: From molecular genetics to clinical medicine
2. BCR-Ab1 inhibition as a modality of CML therapeutics
3. Categorizing genetic tests to identify their ethical, legal and social implications
4. Molecular defect in combined β-galactosidase and neuraminidase deficiency in man
5. Galactosialidosis
6. Global risk assessment in the presymptomatic patient
7. Chronic myelogenous leukemia
8. Cancer risk associated with germline DNA mismatch repair gene mutations
9. Breast and ovarian cancer incidence in BRCA1 mutation carriers
10. Psychological consequences of presymptomatic testing for Huntington's disease
11. Genetic heterogeneity and penetrance analysis of the BRCA1 and 2 genes in breast cancer families
12. Genetic mapping using haplotype, association and linkage methods rapports a locus for severe bipolar disorder (BPI) at 18 g 22-23
13. Factors influencing the reproductive decision after genetic counseling
14. Long-term satification and psychological and social function following bilateral prophylactic mastectomy
15. Genetic Metabolic Diseases; Early Diagnosis and Prenatal Analysis
16. Genetic technology in health care: A global view
17. 1 gangliosidosis
18. DNA diagnostic tools for the 21st century
19. Familial hypercholesterolemia
20. Genomics, Genes and Drugs, Conference Genetics: Genie or Genius. HUGO-HGM
21. Gaucher disease enzymology, genetics and treatment
22. Global profiling of gene expression in cancer using genomics and proteomics
23. Ethical principles and pitfalls of genetic testing for dementia
24. Untangling tau-related dementia
25. Testing for genetic susceptibility to common cancers, clincal and ethical issues
26. Debating the Ethical Future of Human Genetics
27. Effects of enzyme replacement therapy in thirteen Japanese pediatric patients with Gaucher disease
28. Inborn errors of metabolism
29. Initial sequencing and analysis of the human genome
30. BRCA 1 mutations in a population based sample of young women with breast cancer
31. Family members' attitudes towards telling the patient with Alzheimer's disease their diagnosis
32. Current applications of molecular cytogenetic technologies
33. Getting the right drug into the right patient
34. The Troubled Helix; Social and Psychological Implications for the New Human Genetics
35. Mendelian Inheritance in Man
36. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
37. The progressive clinical utility of DNA micro arrays
38. The fragile X gene and its function
39. The Alzheimer diseases
40. How will healthcare delivery benefit from genetics? Conference: Genetics and Health-A Decade of Opportunity
41. Putting stem cells to work
42. The New Genetics: A universal panacea or Pandora's Box?
43. Three-years follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners
44. Panning for gold: Genome-wide scanning for linkages in type 1 diabetes
45. The results of the past 5 years of screening for familial hypercholesterolemia in The Netherlands
46. United Nations Development Report
47. The Universal Declaration on the Human Genome and Human Rights
48. Solidarity and International Co-operation between developed and developing countries concerning the Human Genome
49. The Use of Embryonic Stem Cells in Therapeutic Research
50. Recombinant human α-glucosidase from rabbit milk in Pompe patients
51. Risk factors for Alzheimer's disease
52. Interval cancers in hereditary non-polyposis colorectal cancer
53. Hidden chromosome abnormalities in hematological malignancies detected by multicolour spectral karyotyping
54. The sequence of the human genome
55. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
56. The multistep nature of cancer
57. Macular cherry red spots and myoclonus with dementia: Co-existent neuraminidase and β-galactosidase deficiencies
58. FMRP detection assay for the diagnosis of the fragile X-syndrome
59. Prenatal diagnosis of the fragile X-syndrome
60. The World Health Report; Life in the 21st Century, A Vision for All